BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 28732457)

  • 21. Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry.
    Schellong SM; Goldhaber SZ; Weitz JI; Ageno W; Bounameaux H; Turpie AGG; Angchaisuksiri P; Haas S; Goto S; Zaghdoun A; Farjat A; Nielsen JD; Kayani G; Mantovani LG; Prandoni P; Kakkar AK
    Thromb Haemost; 2019 Oct; 119(10):1675-1685. PubMed ID: 31370075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study.
    Parisi R; Visonà A; Camporese G; Verlato F; Lessiani G; Antignani PL; Palareti G
    Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to treat isolated distal deep vein thrombosis.
    Potere N; Ageno W
    Pol Arch Intern Med; 2023 Aug; 133(7-8):. PubMed ID: 37548526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis.
    Vlazny DT; Pasha AK; Kuczmik W; Wysokinski WE; Bartlett M; Houghton D; Casanegra AI; Daniels P; Froehling DA; White LJ; Hodge DO; McBane RD
    J Thromb Haemost; 2021 Sep; 19(9):2206-2215. PubMed ID: 34060224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical outcomes of different doses of rivaroxaban in patients with isolated distal deep vein thrombosis.
    Wang B; Wang Q; Ji Y; Zhang Y; Qiao T
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101653. PubMed ID: 37490950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer.
    Dentali F; Barco S; Pegoraro S; Di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
    J Thromb Thrombolysis; 2018 Oct; 46(3):404-408. PubMed ID: 30014299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
    Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
    Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation.
    Prandoni P; Lensing AW; Prins MH; Pesavento R; Piccioli A; Sartori MT; Tormene D; Milan M; Vedovetto V; Noventa F; Villalta S; Harenberg J
    Semin Thromb Hemost; 2015 Mar; 41(2):133-40. PubMed ID: 25682083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
    Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
    Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; Bugge JP; Gebel M; Turpie AGG
    TH Open; 2019 Jan; 3(1):e85-e93. PubMed ID: 31249987
    [No Abstract]   [Full Text] [Related]  

  • 34. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.
    Hsu C; Brahmandam A; Brownson KE; Huynh N; Reynolds J; Lee AI; Fares WH; Ochoa Chaar CI
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):169-175.e4. PubMed ID: 30660579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
    Hyers TM; Spyropoulos AC;
    J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
    Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
    J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
    Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
    J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.